###### 

Demographic and immune-virological characteristics of the study population and comparison between H-CSF and L-CSF patients

                                                            Tot naïve n=131     CSF-HIV-RNA \<10000 cp/mL (L-CSF pts) (n=89)   CSF-HIV_RNA \>=10000 cp/mL (H-CSF pts) (n=42)   P value
  --------------------------------------------------------- ------------------- ---------------------------------------------- ----------------------------------------------- ---------
  Female, n (%)\*                                           12 (9)              6 (6)                                          6 (16)                                          0.162
  Age (years), median (IQR)\*                               38 (32--45)         38 (32--45)                                    38 (32--49)                                     0.886
  Time since first HIV diagnosis (months), median (IQR)\*   3.7 (1--21)         4.4 (1.3--15.9)                                3 (1--33)                                       0.718
  Plasma HIV-RNA, Log cp/mL median (IQR)\*                  4.89 (4.22--5.42)   4.69 (4.16--5.26)                              5.23 (4.78--5.85)                               0.002
  CSF-HIV-RNA, Log cp/mL median (IQR)\*                     3.65 (3.04--4.19)   3.44 (2.89--3.67)                              4.76 (4.22--5.09)                               0.0001
  CD4+ T-cell, cell/mmc median (IQR)                        307 (150--417)      320 (154--446)                                 267 (125--366)                                  0.076
  CD4+ T-cell, % median (IQR)                               19 (11--24)         20 (12--25)                                    17 (10--20)                                     0.028
  CD8 T-cell, cell/mmc, median (IQR)                        921 (650--1172)     901 (650--1092)                                1037 (652--1222)                                0.207
  CD8 T-cell, % median (IQR)                                57 (51--66)         55 (49--62)                                    62 (53--73)                                     0.005
  Nadir CD4 t-cell, cell/mmc median (IQR)\*                 282 (130--388)      305 (131--405)                                 209 (125--357)                                  0.157
  Ratio CD4/CD8, median (IQR)\*                             0.33 (0.17--0.45)   0.37 (0.2--0.48)                               0.28 (0.14--0.37)                               0.021
  Symptomatic for headache, n (%)                           14 (11)             4 (5)                                          10 (24)                                         0.001
  HCV co-infection, n (%)\*                                 7/112 (6)           5/76 (6)                                       2/36 (5)                                        0.834
  HBC co-infection, n (%)\*                                 8/98 (8)            6/64 (9)                                       2/34 (6)                                        0.548
  Altered neurocognitive tests\*\*, n (%)                   25/53 (47)          18/40 (45)                                     7/13 (54)                                       0.579
  T-cell Activation                                                                                                                                                            
  CD38+CD8+%, median (IQR)\*                                13 (7--23)          12 (6--21)                                     17 (8--26)                                      0.074
  CD45R0+CD38+CD8+%, median (IQR)\*                         8 (4--16)           7 (4--14)                                      11 (6--18(                                      0.017
  T-cell Maturation/Differentiation                                                                                                                                            
  CD127+CD4+%, median (IQR)\*                               11 (6--15)          11 (7--16)                                     9 (5--13)                                       0.059
  CD127+CD8+%, median (IQR)\*                               26 (21--34)         26 (21--33)                                    25 (21--35)                                     0.656
  CD4SRA+CD4+%, median (IQR)\*                              7 (3--10)           7 (4--10)                                      6 (3--8)                                        0.250
  CD45RA+CD8+%, median (IQR)\*                              17 (13--23)         20 (14--24)                                    16 (10--19)                                     0.007
  CD45R0+CD8+%, median (IQR)\*                              20 (16--29)         20 (15--29)                                    25 (16--32)                                     0.163

H-CSF, patients with CSF HIV-RNA ≥10.000 cp/mL; L-CSF, patients with CSF HIV-RNA\<10.000 cp/mL.
